Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Piper Nicolosi"'
Publikováno v:
European urology focus. 8(3)
Genetic testing is a critical tool in the medical management of disease; however, for variants of uncertain significance there is insufficient evidence to prove a connection between the variant and disease and they should not be used as a basis for c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::595899926873647e06920f7b01ddb74b
https://pubmed.ncbi.nlm.nih.gov/35422376
https://pubmed.ncbi.nlm.nih.gov/35422376
Autor:
Joseph Vijai, Ryan Hausler, Kenneth Offit, Wendy Kohlmann, Wassim Abida, Sophie Hyman, Piper Nicolosi, Heather H. Cheng, Jennie Vagher, Eliezer M. Van Allen, Brian H. Shirts, Maria I. Carlo, Daniel J. Lee, Marianne E Dubard-Gault, Mercy Y. Laurino, Anh D. Le, Eric Q. Konnick, Jacquelyn Powers, Luke Maese, Lauren E. Schwartz, Anne Naumer, Kara N. Maxwell, Lorraine V. Naylor, Bruce Montgomery, Colin C. Pritchard, Joshua D. Schiffman, Casey Morrison, Roman Gulati, Bastien Nguyen, Jill E. Stopfer, Oliver Sartor, Zsofia K. Stadler, Peter S. Nelson, Samantha Greenberg, Judy Garber, Saud H. AlDubayan, Robert L. Nussbaum, Michael Walsh, Diana Mandelker, Michael J. Morris, Elisa Ledet
Publikováno v:
Eur Urol
BACKGROUND: Inherited germline TP53 pathogenic and likely pathogenic mutations (gTP53) cause autosomal dominant multicancer predisposition including Li-Fraumeni syndrome (LFS). However, there is no known association of prostate cancer with gTP53. OBJ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a25f5caee2992fd009f0ea66e51f00cd
https://europepmc.org/articles/PMC8891030/
https://europepmc.org/articles/PMC8891030/
Publikováno v:
Oncotarget
// Oliver Sartor 1 , Shan Yang 2 , Elisa Ledet 1 , Marcus Moses 1 and Piper Nicolosi 2 1 Tulane Cancer Center, Tulane University of School of Medicine, New Orleans, Louisiana, United States 2 Invitae Corporation, Genetics, San Francisco, California,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c768c315662db6c649fd5591776f1068
https://doi.org/10.18632/oncotarget.27456
https://doi.org/10.18632/oncotarget.27456
Publikováno v:
JAMA oncology. 5(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ec49ef53c12a5531c06aacc499aebda
https://pubmed.ncbi.nlm.nih.gov/31294747
https://pubmed.ncbi.nlm.nih.gov/31294747
Autor:
Elisa Ledet, Scott T. Michalski, Piper Nicolosi, Brandy Freschi, Edward D. Esplin, Robert L. Nussbaum, Shan Yang, Oliver Sartor, Erin O’Leary
Publikováno v:
JAMA oncology. 5(4)
Importance Prostate cancer is the third leading cause of cancer-related death in men in the United States. Although serious, most of these diagnoses are not terminal. Inherited risk for prostate cancer is associated with aggressive disease and poorer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ca11ef95945d27b348e87b23297a35f
https://pubmed.ncbi.nlm.nih.gov/30730552
https://pubmed.ncbi.nlm.nih.gov/30730552
Autor:
Keith Nykamp, Michael Anderson, Martin Powers, John Garcia, Blanca Herrera, Yuan-Yuan Ho, Yuya Kobayashi, Nila Patil, Janita Thusberg, Marjorie Westbrook, Scott Topper, Sienna Aguilar, Swaroop Aradhya, Daniel Beltran, Brandon Bunker, Amy Daly, Anne Deucher, Tali Ekstein, Ali Entezam, Karl Erhard, Ed Esplin, Jennifer Fulbright, Amy Fuller, Kristen McDonald Gibson, Tina Hambuch, Rachel Harte, Christy Hartshorne, Eden Haverfield, Nastaran Heidari, Michelle Hogue, Daniela Iacoboni, Britt Johnson, Hio Chung Kang, Rachel Lewis, Shiloh Martin, Sarah McCalmon, Scott Michalski, Cindy Morgan, Laura Murillo, Piper Nicolosi, Karen Ouyang, Carolina Pardo, Rita Quintana, Marina Rabideau, Darlene Riethmaier, Amanda Stafford, Jackie Tahiliani, Chris Tan, S. Paige Taylor, Shu-Huei Wang, Hannah White, Ian Wilson, Tom Winder, Michelle K. Zeman
Publikováno v:
Genetics in Medicine
Purpose The 2015 American College of Medical Genetics and Genomics–Association for Molecular Pathology (ACMG–AMP) guidelines were a major step toward establishing a common framework for variant classification. In practice, however, several aspect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a146539648054315d9d756d7fc859d77
https://doi.org/10.1038/s41436-019-0624-9
https://doi.org/10.1038/s41436-019-0624-9
Publikováno v:
Journal of Clinical Oncology. 37:258-258
258 Background: Pathogenic DNA repair defects are well described in Caucasian (C) men with prostate cancer (PCa) but comparative data on African-American (AA) men are sparse. Methods: Germline testing for DNA repair defects were assayed by Invitae (I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ee4038dcb3cbe329dff99e9fd17b2bb
https://doi.org/10.1200/jco.2019.37.7_suppl.258
https://doi.org/10.1200/jco.2019.37.7_suppl.258
Autor:
Brandy Freschi, Scott T. Michalski, Piper Nicolosi, Martin P. Powers, Erin O'Leary, Ian Wilson, Rita Quintana, Oliver Sartor
Publikováno v:
Journal of Clinical Oncology. 35:5009-5009
5009 Background: Inherited risk for prostate cancer (PCa) is potentially associated with more aggressive disease. Recent data indicate that DNA repair gene abnormalities may be much more common than previously appreciated, especially BRCA2, ATM, CHEK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d72175943c814371ef734e7984bdefa
https://doi.org/10.1200/jco.2017.35.15_suppl.5009
https://doi.org/10.1200/jco.2017.35.15_suppl.5009